Isn't that is the job of CEO and he attend all those investor conference like pilgrimage? then still why company is unknown or investor who knows still think it is a risky business. Data speaks for it, if company would have delivered data as per clinical trial, stock would have been trading much higher, CEO created doubt by releasing post-hoc data. For AD he said they received data day before CTAD, how come he could get ODDs ration in few hours but not other primary end point? Something is fishy